Custody and Control Form (CCF) for Federal Drug Testing Expires Today
Custody and Control Form (CCF) for Federal Drug Testing Expires Today
Attention specimen collectors and employers of DOT-covered employees: The current Federal Drug Testing Custody & Control Form (CCF) expires today, May 31, 2017. However, a newer version of the CCF has not yet been approved by the Office of Management and Budget (OMB). Therefore, collectors should continue to utilize the current (expired) CCF for any urine collections for DOT or Federal drug tests.
There is no definitive date as to the approval of the “new” CCF, so collectors are instructed to continue to use the current CCF (approved May 31, 2014) for all covered collections until the new form is approved. Note: Do not use the new form prior to its approval (laboratories will reject the specimen for testing if the new form is used/sent prior to its approval by the OMB).
The new version of the CCF contains minor changes, including removing the checkbox in front of: “DOT – Specify DOT Agency”. (This way, collectors will not have to check both this box and the box in front of the specific Operating Administration that covers the employee being tested.)
The new form is also expected to include the additional drugs which will be tested under the Federal Drug Testing Program — oxycodone, oxymorphone, hydrocodone and hydromorphone. This is also known as the “expanded opioids panel”. The anticipated date of implementation for these changes is October 1, 2017.
For up-to-date training for professional specimen collectors that engage in Federal collections, Certified Training Solutions offers a comprehensive online Specimen Collector Procedures Training Course (for DOT drug testing). We also offer the hands-on proficiency demonstration training (Component 2) by webcam or in live classes with qualified Instructors.
See training details at: https://certifiedtrainingsolutions.com/dot-specimencollector-training.html
The information presented here is meant to provide general information and guidance. Information is deemed reliable but not guaranteed. Legal advice must be provided in the course of an attorney-client relationship specifically with reference to all the facts of the particular situation under consideration. Such is not the case here, and accordingly, the information presented here must not be relied on as a substitute for obtaining legal advice from a licensed attorney and/or the U.S. Department of Transportation Office of the General Counsel. When in doubt, check with your corporate legal counsel and/or the U.S. Department of Transportation Office of the General Counsel or an agent of the operating agency that covers your industry. Certified Training Solutions is not responsible or liable for any loss or damage relating to the use of the information in this article. Before relying on the material in any important matter, users should carefully evaluate its accuracy, currency, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances.
Attention specimen collectors and employers of DOT-covered employees: The current Federal Drug Testing Custody & Control Form (CCF) expires today, May 31, 2017. However, a newer version of the CCF has not yet been approved by the Office of Management and Budget (OMB). Therefore, collectors should continue to utilize the current (expired) CCF for any urine collections for DOT or Federal drug tests.
There is no definitive date as to the approval of the “new” CCF, so collectors are instructed to continue to use the current CCF (approved May 31, 2014) for all covered collections until the new form is approved. Note: Do not use the new form prior to its approval (laboratories will reject the specimen for testing if the new form is used/sent prior to its approval by the OMB).
The new version of the CCF contains minor changes, including removing the checkbox in front of: “DOT – Specify DOT Agency”. (This way, collectors will not have to check both this box and the box in front of the specific Operating Administration that covers the employee being tested.)
The new form is also expected to include the additional drugs which will be tested under the Federal Drug Testing Program — oxycodone, oxymorphone, hydrocodone and hydromorphone. This is also known as the “expanded opioids panel”. The anticipated date of implementation for these changes is October 1, 2017.
For up-to-date training for professional specimen collectors that engage in Federal collections, Certified Training Solutions offers a comprehensive online Specimen Collector Procedures Training Course (for DOT drug testing). We also offer the hands-on proficiency demonstration training (Component 2) by webcam or in live classes with qualified Instructors.
See training details at: https://certifiedtrainingsolutions.com/dot-specimencollector-training.html
The information presented here is meant to provide general information and guidance. Information is deemed reliable but not guaranteed. Legal advice must be provided in the course of an attorney-client relationship specifically with reference to all the facts of the particular situation under consideration. Such is not the case here, and accordingly, the information presented here must not be relied on as a substitute for obtaining legal advice from a licensed attorney and/or the U.S. Department of Transportation Office of the General Counsel. When in doubt, check with your corporate legal counsel and/or the U.S. Department of Transportation Office of the General Counsel or an agent of the operating agency that covers your industry. Certified Training Solutions is not responsible or liable for any loss or damage relating to the use of the information in this article. Before relying on the material in any important matter, users should carefully evaluate its accuracy, currency, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances.